An increasing amount of evidence supports the repressor role of FOXP2 upon the transcription of its target genes, such as SRPX2/uPAR complex (18) and DLL3 (19), which are involved in oncogenic progression of different types of cancers. The gene discussed is PLAUR; the disease is cancer.